27.06.2024 15:01:01 - dpa-AFX: GNW-Adhoc: KFSH&RC Leads Global Healthcare Revolution with AI and Robotics
RIYADH, Saudi Arabia, June 27, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist
Hospital & Research Centre (KFSH&RC) is at the forefront of the global AI and
robotics revolution. These technological advancements, driven by Saudi Vision
2030, are set to unlock an estimated $15 billion to $27 billion in economic
value for the Kingdom's medical sector by 2030, in addition to their pivotal
role in streamlining processes and transforming patient care.
Robotic-assisted surgeries are a hallmark of KFSH&RC's technological
integration. In 2023 alone, KFSH&RC performed 1,195 robotic-assisted procedures,
most notably, the world's first fully robotic liver transplantation,
highlighting KFSH&RC's pioneering role in using robotics to enhance surgical
precision and patient recovery.
Complementing these surgical advancements, Whole Genome Sequencing (WGS), has
become a cornerstone of KFSH&RC's approach to early detection and treatment of
genetic disorders. By conducting over 7,000 WGS tests in 2023 to date, the
hospital has enabled the identification of genetic predispositions to various
diseases. This dual focus on cutting-edge surgical technology and comprehensive
genetic analysis positions KFSH&RC at the forefront of medical innovation,
ensuring that patients receive the most precise and effective care possible.
KFSH&RC's laboratories are also equipped with automated systems that streamline
diagnostics and testing processes. These systems enhance accuracy and speed,
allowing for quicker diagnosis and treatment of patients. Over 1.5 million tests
were processed, reducing turnaround times by 30%.
Recognizing the transformative potential of digital health, KFSH&RC has embraced
AI-driven solutions across various departments. In 2023, AI tools in radiology
improved diagnostic accuracy by 25% and reduced misdiagnosis rates by 18%,
enhancing the detection and treatment of diseases such as cancer and
cardiovascular disorders. By leveraging AI and advanced biotechnological
methods, KFSH&RC successfully produced CAR-T cells internally for cancer
treatment, reducing the cost of treatment and alleviating patient suffering.
Central to KFSH&RC's advancements is its state-of-the-art Capacity Command
Centre, the primary source for data-driven decision-making. It monitors patient
movements to maintain care quality, adhere to standard procedures, and predict
demand volumes to mitigate risks. Utilizing AI-driven strategies, the Centre has
executed over 170,000 intervention procedures since its launch in September
2021, reducing bed waiting times from 32 hours to 6 hours and cutting emergency
department waiting times by 14%.
Looking ahead, KFSH&RC continues to integrate advanced technologies into the
global healthcare ecosystem as a smart hospital and remains committed to driving
innovation and excellence in medical care.
It is noteworthy that KFSH&RC has been ranked first in the Middle East and
Africa and 20th globally, in the list of the world's top 250 Academic Medical
Centres for the second consecutive year and recognized as the most valuable
healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand
Finance rankings. Additionally in the same year, it was ranked among the world's
best 250 hospitals by Newsweek magazine.
For further information, please contact:
Mr. Essam AlZahrani, Acting Head of Media Affairs, 0555254429
Mr. Abdullah Alown, Media Coordination Officer, 0556294232
Photo available: https://www.globenewswire.com/NewsRoom/AttachmentNg/16594984-
1eaf-488b-ada2-1291d75bf71c
Â